NYXOAH SA - ORDINARY S

Conditional Issuance of Shares

16 апр 2025 01:00:00 Источник Nasdaq GlobeNewswire

Nyxoah Provides Update on FDA Approvable Letter for Genio System

08 апр 2025 00:00:00 Источник Nasdaq GlobeNewswire

FDA Issues Nyxoah an Approvable Letter for its Genio® System

26 мар 2025 02:00:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

13 мар 2025 01:00:00 Источник Nasdaq GlobeNewswire

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

10 мар 2025 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

03 мар 2025 15:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

19 фев 2025 00:05:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

20 янв 2025 15:30:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

20 дек 2024 15:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

13 дек 2024 01:05:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

27 ноя 2024 15:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

20 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024

19 ноя 2024 00:00:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

18 ноя 2024 15:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports Third Quarter Financial and Operating Results

06 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Appoints John Landry as Chief Financial Officer

04 ноя 2024 15:45:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

25 окт 2024 15:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

22 окт 2024 15:30:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

15 окт 2024 15:30:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

09 окт 2024 15:35:00 Источник Nasdaq GlobeNewswire